DEA, HHS extend telehealth controlled substance prescribing flexibilities for fourth time

The extension, released shortly before the flexibilities were set to expire at the end of 2025, gives regulators more time to ...
Becker's Hospital Review

DEA extends telemedicine prescribing flexibilities through 2026

DEA extends telemedicine prescribing flexibilities through 2026, allowing remote controlled substance prescriptions without in-person visits.
Fierce Healthcare

DEA issues 4th extension of telehealth controlled substance flexibilities as debate enters 6th year

The Drug Enforcement Administration (DEA) published a yearlong extension of telemedicine prescribing flexibilities for ...
Monthly Prescribing Reference

DEA Allows Electronic Transfer of Controlled Substance Prescriptions for Initial Fill

Electronic prescriptions for schedules II-V controlled substances can be transferred between registered retail pharmacies for initial filling effective August 28, 2023, according to the Drug ...
MobiHealthNews

DEA, HHS extend telemedicine flexibilities for remote prescribing of controlled substances

The extension allows providers to continue remotely prescribing Schedule II–V controlled substances under specific conditions ...
University of Texas at San Antonio

10.17 Controlled Substances in Research

The University of Texas at San Antonio (UTSA) provides administrative and procedural support to Principal Investigators (PIs) who possess and use Controlled Substances and precursor chemicals in ...